Matches in Wikidata for { <http://www.wikidata.org/entity/Q51031213> ?p ?o ?g. }
- Q51031213 description "2014 nî lūn-bûn" @default.
- Q51031213 description "2014年の論文" @default.
- Q51031213 description "2014年学术文章" @default.
- Q51031213 description "2014年学术文章" @default.
- Q51031213 description "2014年学术文章" @default.
- Q51031213 description "2014年学术文章" @default.
- Q51031213 description "2014年学术文章" @default.
- Q51031213 description "2014年学术文章" @default.
- Q51031213 description "2014年學術文章" @default.
- Q51031213 description "2014年學術文章" @default.
- Q51031213 description "2014年學術文章" @default.
- Q51031213 description "2014年學術文章" @default.
- Q51031213 description "2014年學術文章" @default.
- Q51031213 description "2014년 논문" @default.
- Q51031213 description "article científic" @default.
- Q51031213 description "article scientific" @default.
- Q51031213 description "article scientifique" @default.
- Q51031213 description "articol științific" @default.
- Q51031213 description "articolo scientifico" @default.
- Q51031213 description "artigo científico" @default.
- Q51031213 description "artigo científico" @default.
- Q51031213 description "artigo científico" @default.
- Q51031213 description "artikel ilmiah" @default.
- Q51031213 description "artikull shkencor" @default.
- Q51031213 description "artikulong pang-agham" @default.
- Q51031213 description "artykuł naukowy" @default.
- Q51031213 description "artículo científico publicado en 2014" @default.
- Q51031213 description "artículu científicu" @default.
- Q51031213 description "bilimsel makale" @default.
- Q51031213 description "bài báo khoa học" @default.
- Q51031213 description "naučni članak" @default.
- Q51031213 description "scienca artikolo" @default.
- Q51031213 description "scientific article published on 20 October 2014" @default.
- Q51031213 description "scientific article published on 20 October 2014" @default.
- Q51031213 description "scientific article published on 20 October 2014" @default.
- Q51031213 description "teaduslik artikkel" @default.
- Q51031213 description "tieteellinen artikkeli" @default.
- Q51031213 description "tudományos cikk" @default.
- Q51031213 description "vedecký článok" @default.
- Q51031213 description "vetenskaplig artikel" @default.
- Q51031213 description "videnskabelig artikel" @default.
- Q51031213 description "vitenskapelig artikkel" @default.
- Q51031213 description "vitskapeleg artikkel" @default.
- Q51031213 description "vědecký článek" @default.
- Q51031213 description "wetenschappelijk artikel" @default.
- Q51031213 description "wissenschaftlicher Artikel" @default.
- Q51031213 description "επιστημονικό άρθρο" @default.
- Q51031213 description "мақолаи илмӣ" @default.
- Q51031213 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q51031213 description "научна статия" @default.
- Q51031213 description "научная статья" @default.
- Q51031213 description "научни чланак" @default.
- Q51031213 description "научни чланак" @default.
- Q51031213 description "מאמר מדעי" @default.
- Q51031213 description "مقالة علمية نشرت في 20 أكتوبر 2014" @default.
- Q51031213 description "২০ অক্টোবর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q51031213 description "บทความทางวิทยาศาสตร์" @default.
- Q51031213 description "სამეცნიერო სტატია" @default.
- Q51031213 name "Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer." @default.
- Q51031213 name "Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer." @default.
- Q51031213 type Item @default.
- Q51031213 label "Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer." @default.
- Q51031213 label "Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer." @default.
- Q51031213 prefLabel "Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer." @default.
- Q51031213 prefLabel "Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer." @default.
- Q51031213 P1433 Q51031213-0D36B3DB-D1AD-4FCA-9B8B-D2E2A8BA1BA4 @default.
- Q51031213 P1476 Q51031213-F80A779D-A3A1-4CCE-BE04-DEE6899F4B12 @default.
- Q51031213 P2093 Q51031213-2E9CC6CC-018C-4882-8416-3A3126629282 @default.
- Q51031213 P2093 Q51031213-404019F9-4438-4AE2-9EAF-9921DD36CA20 @default.
- Q51031213 P2093 Q51031213-5F2B117B-273C-43A7-AE29-02EAE2EC80A9 @default.
- Q51031213 P2093 Q51031213-66F77894-20C3-4C5A-B85D-E7D30B45CB2C @default.
- Q51031213 P2093 Q51031213-6E985F4A-9727-4A7D-B048-92CEE36D9CB7 @default.
- Q51031213 P2093 Q51031213-7EC89116-6CC0-4F2D-BE00-DD3D699CB765 @default.
- Q51031213 P2093 Q51031213-8DF5685D-13E5-42AA-8CF1-330BA06B624D @default.
- Q51031213 P2093 Q51031213-8F16AC65-1CE5-4D14-814B-147080B1AE74 @default.
- Q51031213 P2093 Q51031213-912787A5-A46C-4B86-9049-537DE3288DB0 @default.
- Q51031213 P2093 Q51031213-91D28782-4003-41AE-8750-9BC154ED144C @default.
- Q51031213 P2093 Q51031213-A525992C-126E-4B22-A902-993D7632736F @default.
- Q51031213 P2093 Q51031213-A8B90625-E019-4235-9F09-AE1CAE0D133A @default.
- Q51031213 P2093 Q51031213-A9FDA5C7-913B-4281-87CF-089C07A3B3B7 @default.
- Q51031213 P304 Q51031213-F3AF502E-5CDF-4521-A178-1317033410ED @default.
- Q51031213 P31 Q51031213-B548B339-44A7-48DB-B3DB-2A794905CE50 @default.
- Q51031213 P356 Q51031213-44526C67-B0CF-4D5E-8D9C-E33D93235AC2 @default.
- Q51031213 P433 Q51031213-E6550736-8D88-415B-B0D9-CC7DD8C53C06 @default.
- Q51031213 P478 Q51031213-922FC2B8-3786-4FDC-B498-A2CB653AEC5B @default.
- Q51031213 P577 Q51031213-9198CE85-F400-4F39-9FD1-AC9CE5811245 @default.
- Q51031213 P698 Q51031213-E595A18A-2A2A-4CB2-A4B3-DFA3832194CB @default.
- Q51031213 P921 Q51031213-95834198-13CA-469F-84EF-D6BB14669899 @default.
- Q51031213 P356 J.RADONC.2014.08.014 @default.
- Q51031213 P698 25441058 @default.
- Q51031213 P1433 Q14251029 @default.
- Q51031213 P1476 "Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer." @default.
- Q51031213 P2093 "Andre Konski" @default.
- Q51031213 P2093 "Anthony Shields" @default.
- Q51031213 P2093 "Beth Adaire" @default.
- Q51031213 P2093 "Erin McSpadden" @default.
- Q51031213 P2093 "Gail Duncan" @default.
- Q51031213 P2093 "Joshua E Meyer" @default.
- Q51031213 P2093 "Michael J Hall" @default.
- Q51031213 P2093 "Michael Joiner" @default.